The effect of a pneumococcal conjugate vaccine on the risk of otitis media with effusion at 7 and 24 months of age

International Journal of Pediatric Otorhinolaryngology

Volumn 67, Issue 11, 2003, Pages 1235-1242

  Straetemans, M ^a,b   Palmu, A ^a   Auranen, K ^a   Zielhuis, G A ^b   Kilpi, T ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Infants; Interaction; Otitis media with effusion; Pneumococcal conjugate vaccine; Subgroups

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACUTE DISEASE; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DAY CARE; DEVICE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EFFUSION; FEMALE; FINLAND; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFANT; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OTITIS MEDIA; OTOSCOPY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SIBLING; TYMPANOSTOMY TUBE; VACCINATION;

EID: 0242302322     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2003.08.001     Document Type: Article

References (23)

1. Senturia B.H., Bluestone C.D., Klein J.O., Lim D.J., Paradise J.L. Report of the ad hoc committee on definition and classification on otitis media and otitis media with effusion. Ann. Otol. Rhinol. Laryngol. Suppl. 89(Suppl. 68):1980;3-4.
2. C.D. Bluestone, Definitions, terminology and classification., in: R.M. Rosenfeld, C.D. Bluestone (Eds.), Evidence-Based Otitis Media. B.C. Decker Inc., Hamilton, 1999, pp. 85-103.
3. Zielhuis G.A., Rach G.H., Van den Bosch A., Van den Broek P. The prevalence of otitis media with effusion: a critical review of the literature. Clin. Otolaryngol. 15(3):1990;283-288.
4. E.J. Midgley, C. Dewey, K. Pryce, A.R. Maw, The frequency of otitis media with effusion in British pre-school children: a guide for treatment, ALSPAC Study Team, Clin. Otolaryngol. 25 (6) 2000 485-491.
5. Kontiokari T., Niemela M., Uhari M. Middle ear effusion among children diagnosed and treated actively for acute otitis media. Eur. J. Pediatr. 157(9):1998;731-734.
6. Alho O.P., Oja H., Koivu M., Sorri M. Chronic otitis media with effusion in infancy. How frequent is it? How does it develop? Arch. Otolaryngol. Head Neck Surg. 121(4):1995;432-436.
7. Zielhuis G.A., Rach G.H., Van den Broek P. The natural course of otitis media with effusion in pre-school children. Eur. Arch. Otorhinolaryngol. 247(4):1990;215-221.
8. Straetemans M., Van Heerbeek N., Tonnaer E., Ingels K.J.A.O., Rijkers G.T., Zielhuis G.A. A comprehensive model for the aetiology of otitis media with effusion. Med. Hypotheses. 57(6):2001;784-791.
9. C. Butler, J. Van der Voort, Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children (Cochrane review), in: The Cochrane Library, 2001, Issue 2, Update Software, Oxford.
10. Kaplan B., Wandstrat T.L., Cunningham J.R. Overall cost in the treatment of otitis media. Pediatr. Infect. Dis. J. 16(Suppl. 2):1997;S9-11.
11. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R.et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanent Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19(3):2000;187-195.
12. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E.et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344(6):2001;403-409.
13. M. Straetemans, E. Sanders, R.H. Veenhoven, A.G.M. Schilder, R. Damoiseaux, G. Zielhuis, Pneumococcal vaccines for preventing otitis media (Cochrane review), in: The Cochrane Library, 2002, Issue 2, Updated Software, Oxford.
14. Ofran Y., Ofran A. A pneumococcal conjugate vaccine and acute otitis media. N. Engl. J. Med. 344(22):2001;1719.
15. Engel J., Anteunis L., Volovics A., Hendriks J., Marres E. Risk factors of otitis media with effusion during infancy. Int. J. Pediatr. Otorhinolaryngol. 48(3):1999;239-249.
16. Rovers M.M., Hofstad E.A., Franken Van den Brand K.I., Straatman H., Ingels K., Van der Wilt G.J.et al. Prognostic factors for otitis media with effusion in infants. Clin. Otolaryngol. 23(6):1998;543-546.
17. Rovers M.M., Zielhuis G.A., Ingels K., Van der Wilt G.J. Day-care and otitis media in young children: a critical overview. Eur. J. Pediatr. 158(1):1999;1-6.
18. Paradise J.L., Rockette H.E., Colborn D.K., Bernard B.S., Smith C.G., Kurs-Lasky M.et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 99(3):1997;318-333.
19. Uhari M., Mantysaari K., Niemela M. A meta-analytic review of the risk factors for acute otitis media. Clin. Infect. Dis. 22(6):1996;1079-1083.
20. Bluestone C.D. Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment. Int. J. Pediatr. Otorhinolaryngol. 42(3):1998;207-223.
21. Palmu A., Puhakka H., Rahko T., Takala A.K. Diagnostic value of tympanometry in infants in clinical practice. Int. J. Pediatr. Otorhinolaryngol. 49(3):1999;207-213.
22. P.J. Diggle, K.-Y. Liang, S.L. Zeger, Analysis of Longitudinal Data, Oxford, 1994.
23. Paradise J.L., Feldman H.M., Campbell T.F., Dollaghan C.A., Colborn D.K., Bernard B.S.et al. Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. N. Engl. J. Med. 344(16):2001;1179-1187.